Page last updated: 2024-09-04

cilomilast and cilostamide

cilomilast has been researched along with cilostamide in 1 studies

Compound Research Comparison

Studies
(cilomilast)
Trials
(cilomilast)
Recent Studies (post-2010)
(cilomilast)
Studies
(cilostamide)
Trials
(cilostamide)
Recent Studies (post-2010) (cilostamide)
1621342192067

Protein Interaction Comparison

ProteinTaxonomycilomilast (IC50)cilostamide (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.005
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)0.005
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.5775
Platelet-activating factor receptorHomo sapiens (human)3.687
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.005
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)0.0502
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)0.0362

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hughes, RA; Manallack, DT; Thompson, PE1

Reviews

1 review(s) available for cilomilast and cilostamide

ArticleYear
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
    Journal of medicinal chemistry, 2005, May-19, Volume: 48, Issue:10

    Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines

2005